IXHL
Incannex Healthcare Limited$3.56
LiveJun 18, 2026
Market cap
$42.59M
52w range
2.49 – 49.80
P / E
—
EPS
—
Volume
266.5K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Incannex Healthcare Limited’s valuation06-10today
- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility11d
- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility11d
- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility11d
- Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development40d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.78% | -8.72% | -2.20% | +19.06% | -72.91% | -66.85% | -40.67% | -93.65% | -99.20% | -99.20% | -99.20% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$3.55
Bid
$3.29
2 sh
Ask
$4.05
2 sh
Spread
$0.760
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibilityglobenewswire.com·Jun 10, 2026
- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibilityglobenewswire.com·Jun 10, 2026
- Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibilityglobenewswire.com·Jun 10, 2026
- Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Developmentglobenewswire.com·May 12, 2026
- Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Developmentglobenewswire.com·May 12, 2026
Recent analyst activity
DB- Jun 08, 2026GradeBuyIncannex initiated with a Buy at Alliance GlobalAlliance Global Partners
Peers
No peer list available for IXHL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|